Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Docagne

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
The Biochemical Journal|October 27, 2007
Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2)Fernando Correa, Fabian Docagne, Diego Clemente, et al.
The Lancet. Neurology|August 30, 2016
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunitiesRichard Macrez, Peter K Stys, Denis Vivien, et al.
Expert Opinion on Therapeutic Targets|January 23, 2008
Therapeutic potential of CB2 targeting in multiple sclerosisFabian Docagne, Leyre Mestre, Frida Loría, et al.
Neuropharmacology|November 15, 2011
tPA in the injured central nervous system: different scenarios starring the same actor?Sighild Lemarchant, Fabian Docagne, Evelyne Emery, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 30, 2018
Reduced spinal cord parenchymal cerebrospinal fluid circulation in experimental autoimmune encephalomyelitisAntoine P Fournier, Maxime Gauberti, Aurélien Quenault, et al.
Brain, Behavior, and Immunity|February 12, 2011
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cellsFernando Correa, Miriam Hernangómez-Herrero, Leyre Mestre, et al.
Theranostics|March 7, 2018
Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous SystemMaxime Gauberti, Antoine P Fournier, Fabian Docagne, et al.
Biochemical Pharmacology|October 14, 2008
A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cellsFernando Correa, Fabian Docagne, Leyre Mestre, et al.
Neuroimmunomodulation|December 13, 2007
Cannabinoid system and neuroinflammation: implications for multiple sclerosisFernando Correa, Fabian Docagne, Leyre Mestre, et al.
Glia|May 22, 2009
Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammationOrla Cunningham, Suzanne Campion, V Hugh Perry, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
The Biochemical Journal|October 27, 2007
Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2)Fernando Correa, Fabian Docagne, Diego Clemente, et al.
The Lancet. Neurology|August 30, 2016
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunitiesRichard Macrez, Peter K Stys, Denis Vivien, et al.
Expert Opinion on Therapeutic Targets|January 23, 2008
Therapeutic potential of CB2 targeting in multiple sclerosisFabian Docagne, Leyre Mestre, Frida Loría, et al.
Neuropharmacology|November 15, 2011
tPA in the injured central nervous system: different scenarios starring the same actor?Sighild Lemarchant, Fabian Docagne, Evelyne Emery, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 30, 2018
Reduced spinal cord parenchymal cerebrospinal fluid circulation in experimental autoimmune encephalomyelitisAntoine P Fournier, Maxime Gauberti, Aurélien Quenault, et al.
Brain, Behavior, and Immunity|February 12, 2011
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cellsFernando Correa, Miriam Hernangómez-Herrero, Leyre Mestre, et al.
Theranostics|March 7, 2018
Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous SystemMaxime Gauberti, Antoine P Fournier, Fabian Docagne, et al.
Biochemical Pharmacology|October 14, 2008
A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cellsFernando Correa, Fabian Docagne, Leyre Mestre, et al.
Neuroimmunomodulation|December 13, 2007
Cannabinoid system and neuroinflammation: implications for multiple sclerosisFernando Correa, Fabian Docagne, Leyre Mestre, et al.
Glia|May 22, 2009
Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammationOrla Cunningham, Suzanne Campion, V Hugh Perry, et al.
Pageof 6